Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Spine J. 2015 Apr 23;15(9):2045–2054. doi: 10.1016/j.spinee.2015.04.026

Figure 5. Infliximab is released from CHS within FibGen in the presence of plasmin.

Figure 5

Cumulative drug release from FibGen with 320 μg infliximab loaded CHS in the presence of plasmin, a broad spectrum serine proteinase. Infliximab was released from CHS within FibGen in the presence of plasmin, but the rate of release increased after some initial degradation after approximately day 10.